已收盤 12-07 16:00:00 美东时间
0.000
0.00%
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China.
2023-11-07 21:28
Rumble CEO Chris Pavlovski Comments On Upcoming Lock Up Expiration, Says Will N...
2023-09-05 07:33
Flow Traders U.S. LLC purchased a new stake in shares of CF Acquisition Corp. I...
2023-03-10 19:58
CF Acquisition Corp. IV (NASDAQ:CFIV – Get Rating) saw a significant drop in sh...
2023-03-07 13:03
Shares of CF Acquisition Corp. IV (NASDAQ:CFIV – Get Rating) saw unusually-high...
2023-02-26 16:03
Glazer Capital LLC raised its stake in shares of CF Acquisition Corp. IV (NASDA...
2023-02-23 22:23
UBS Oconnor LLC lessened its holdings in shares of CF Acquisition Corp. IV (NAS...
2023-02-19 02:01
CF Acquisition Corp. IV (NASDAQ:CFIVW – Get Rating) was the recipient of a sign...
2023-02-16 11:11
Cubist Systematic Strategies LLC trimmed its position in shares of CF Acquisiti...
2023-02-13 00:42
CF Acquisition Corp. IV (NASDAQ:CFIVW – Get Rating) saw a large decline in shor...
2023-01-22 05:11